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• The MMPs are endopeptidases that can cleave virtually any
component of the ECM
• The MMPs are synthesized as inactive ZYMOGENS (pro-MMPs). 
They are kept inactive by an interaction between a cysteine-
sulphydryl group in the propeptide domain and the zinc ion bound to 
the catalytic domain: activation requires proteolytic removal of the
propeptide prodomain
• MMPs can promote cancer progression by increasing cancer-cell
growth,migration, invasion, metastasis and angiogenesis
(Egeblad & Werb, 2002)
Regulation of  MMPs
The activity of MMPs is regulated at three levels: 
synthesis (primarily transcription), proteolytic
activation of the zymogen and inhibition of proteolitic
activity by specific endogenous inhibitors
(Rittié & Fisher, 2002)
UV-induced signalig cascades
 Activation of cell surface 
growth factor and 
cytokine receptors
 Inhibition of transforming 
growth factor (TGF)-β
signaling
 Activation is enhanced by 
concomitant production of 
ROS
(Rittié & Fisher, 2002)
Metalloproteinases and photoaging
 UV irradiation of human skin 
causes extracellular matrix 
degradation via induction of 
transcription factor AP-1, 
and subsequent increases 
MMP production
Inhibition of the enzymatic activity of MMPs
 TIMPS - tissue inhibitors of metalloproteinases
 Direct inhibition of the catalytic domain
 Chelation of Zn 2+
Antioxidant activity and MMP inhibition
 Oral administration of GTP resulted in inhibition of UVB-
induced expression of matrix degrading MMP (MMP-2, 
MMp-3, MMP-7 and MMP-9) in hairless mouse skin
(Vayalil et al., 2004)
 Metabolites of Maritime Pine Bark Extract (Grimm et al., 
2004)
Pothomorphe umbellata L. Miq
•Pothomorphe umbellata, a plant of Piperaceae family, is 
widely used in Brazilian folk medicine for treatment of liver 
diseases and healing of skin wounds.
•Pariparoba
•The roots of P. umbellata were included in the first edition of 
the Brazilian Pharmacopea
Pothomorphe umbellata L. Miq
Pothomorphe umbellata L. Miq
in vitro results
• Crude root ethanolic extracts of P. umbellata demonstrated
a significant activity in the prevention of in vitro spontaneous brain lipid
peroxidation evaluated by TBARS and chemiluminescence (CL) emission (Barros 
et al., 1996)
This activity was attributed to 4-nerolidylcathecol, a compound isolated from
the hexane extracts of roots and leaves of P. umbellata
• the total reactive potential of the P. umbellata extract was higher than that 
obtained for the isolated 4-NC, suggesting the presence in the extracts of 





• Topical application of P. umbellata root extract reduced the
lipid peroxidation of skin homogenates (TBARS and CL) in 
97%1
• antioxidant activity 2.5 higher than that of α-tocopherol1
• Preserved endogenous α-tocopherol concentration in the
skin, after acute irradiation with UVB2
Pothomorphe umbellata L. Miq
1Ropke, Dissertação de Mestrado 1998;
2Ropke et al., Photochem. Photobiol. 2003 
3Ropke et al., Clin. Exp. Dermatol., 2005, 4Ropke et al., Photochem. Photobiol.
2006 
in vivo results
• P. umbellata extract was able to reduce the incidence of 
visible and histological skin alterations in chronically UV-
irradiated mice
Pothomorphe umbellata L. Miq

Inhibition of MMP-9 induction after acute UVB 
exposure
• UVB dose: 0.23 J/cm2
• Sacrifice time: 2h after 
irradiation
Effect of topical application of 
P. umbellata extract on MMP-2 and 9 on the skin 
chronically exposed to UVB radiation
 Groups: control, UVB, UVB+vehicle, UVB+P. umbellata
(treated 2 h prior irradiation for 4 weeks)
 Lamp: UVB Philips TL 12RS 40W
 Dose: 13.17 KJ/m2 (4 times weekly)
 Sacrifice: 2 h after irradiation
 Zimography – Acrilamid SDS-page gel, containing 0,5% 
of gelatin





G- Irradiated group treated with vehicle
















Additional compounds with MMP inhibitory activity
 Fractioning of P. umbellata root extract
 In vitro gelatin zymography with fractions without 4-NC
Results
P    F1   F2    F3     F4   F5     F7   F8

Conclusions
• Either by its previously demonstrated antioxidant 
properties, as by the inhibitory effects on MMPs hereby 
shown, our combined data may provide a rational basis 
for the use of standardized P. umbellata extract in 
prophylaxis and therapy of photodamage
• There are other compounds in the P. umbellata extract 
with MMP inhibition activity
Patent USP/Fapesp PCT/BR03/00134 "Use of Pothomorphe umbellata
extract, composition on basis of Pothomorphe umbellata extract and
method of application of the Pothomorphe umbellata extract", 2003 
Patent USP/Fapesp PI 0504720-0 “Process of obtainment of cathecol and
derivatives as from plants of the gender Pothomorphe, formulations and
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